Volume 15 Supplement 1
Spots and dots in the bones
© Tyler 2015
Published: 2 October 2015
Cancer imaging is frequently at the cutting edge of new imaging techniques which are often rapidly incorporated into routine use.
Skeletal metastatic disease is a frequent complication of neoplastic conditions, and results in specific challenges to the general radiologist and specialist oncological radiologist alike.
Non-neoplastic conditions and normal variants may simulate skeletal metastases, and the radiologist must recognise such cases and avoid over-investigation and unnecessary treatment.
This lecture will briefly review standard imaging techniques and demonstrate normal appearances, normal variants and non-neoplastic lesions that mimic primary and secondary skeletal malignancy, and will then review a spectrum of malignancy-associated bone lesions with the use of standard and more specialised imaging techniques, including PET MRI, PET CT and diffusion weighted imaging,.
Expected post treatment imaging findings, and treatment-associated complications will also be discussed.
- Ferraro R, Agarwal A, Martin-Macintosh EL, Peller PJ, Subramaniam RM: MR imaging and PET/CT in diagnosisand management of multiple myeloma. Radiographics. 2015, 35 (2): 438-54. 10.1148/rg.352140112. doi: 10.1148/rg.352140112. PMID: 25763728PubMedView ArticleGoogle Scholar
- Subhawong TK, Wilky BA: Value added :functional MR imagingin management of bone and soft tissue sarcomas. Curr Opin Oncol. 2015, 27 (4): 323-31. 10.1097/CCO.0000000000000199. doi: 10.1097/CCO.0000000000000199. PMID:26049272PubMedView ArticleGoogle Scholar
- Del Vescovo R, Frauenfelder G, Giurazza F, Piccolo CL, Cazzato RL, Grasso RF, Schena E, Zobel BB: Role ofwhole-body diffusion-weighted MRI in detecting bone metastasis. Radiol Med. 2014, 119 (10): 758-66. 10.1007/s11547-014-0395-y. doi: 10.1007/s11547-014-0395-y. Epub 2014 Mar 18PubMedView ArticleGoogle Scholar
- Alexiou E, Georgoulias P, Valotassiou V, Georgiou E, Fezoulidis I, Vlychou M: Multifocal septic osteomyelitis mimicking skeletalmetastatic diseasein a patient with prostate cancer. Hell J Nucl Med. 2015, 18 (1): 77-8. doi: 10.1967/s002449910168PubMedGoogle Scholar
- Beiderwellen K, Huebner M, Heusch P, Grueneisen J, Ruhlmann V, Nensa F, Kuehl H, Umutlu L, Rosenbaum-Krumme S, Lauenstein TC: Whole-body[18F]FDG PET/MRI vs. PET/CT in the assessment of bonelesions in oncological patients: initial results. Eur Radiol. 2014, 24 (8): 2023-30. 10.1007/s00330-014-3229-3. doi: 10.1007/s00330-014-3229-3. Epub 2014 Jun 8PubMedView ArticleGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.